Literature DB >> 34297657

The Role of a Resilient Information Infrastructure in COVID-19 Vaccine Uptake in Ontario.

Raquel Duchen1, Carina Iskander2, Hannah Chung3, J Michael Paterson4, Jeffrey C Kwong5, Susan E Bronskill6, Laura Rosella7, Astrid Guttmann8.   

Abstract

The COVID-19 pandemic has highlighted the need for a robust and nimble public health data infrastructure. ICES - a government-sponsored, independent, non-profit research institute in Ontario, Canada - functions as a key component of a resilient information infrastructure and an enabler of data co-production, contributing to Ontario's response to the COVID-19 pandemic as part of a learning health system. Linked data on the cumulative incidence of infection and vaccination at the neighbourhood level revealed disparate uptake between areas with low versus high risk of COVID-19. These data were leveraged by the government, service providers, media and the public to inform a more efficient and equitable vaccination strategy.
Copyright © 2021 Longwoods Publishing.

Entities:  

Year:  2021        PMID: 34297657     DOI: 10.12927/hcq.2021.26553

Source DB:  PubMed          Journal:  Healthc Q        ISSN: 1710-2774


  3 in total

1.  COVID-19 vaccination coverage in deprived populations living in segregated colonies: A nationwide cross-sectional study in Hungary.

Authors:  János Sándor; Ferenc Vincze; Maya Liza Shrikant; László Kőrösi; László Ulicska; Karolina Kósa; Róza Ádány
Journal:  PLoS One       Date:  2022-02-28       Impact factor: 3.240

2.  Supporting policy and practice in Ontario through ICES' Applied Health Research Question (AHRQ) program.

Authors:  Lisa Ishiguro; Diana Ann An; Lesley Plumptre; Jenine Paul; Graham Mecredy; Kathy Li; Minnie M Ho; Susan E Bronskil; J Charles Victor; Michael J Schull; J Michael Paterson
Journal:  Int J Popul Data Sci       Date:  2021-10-28

3.  The influence of place on COVID-19 vaccine coverage in Alberta: A multilevel analysis.

Authors:  Yuba Raj Paudel; Crystal Du; Shannon Elizabeth MacDonald
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.